Fatty acid supplement
Medium-chain triglyceride
Treatment of long-chain fatty acid disorders and glucose transporter type 1 deficiency syndrome
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AX Various alimentary tract and metabolism products
A16AX17 Triheptanoin
D11465 Triheptanoin (USAN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Triheptanoin
D11465 Triheptanoin (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11465
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11465
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D11465